174 related articles for article (PubMed ID: 37132361)
1. Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study.
Yan VKC; Wan EYF; Ye X; Mok AHY; Lai FTT; Chui CSL; Li X; Wong CKH; Li PH; Ma T; Qin S; Lau CS; Wong ICK; Chan EWY
Emerg Microbes Infect; 2023 Dec; 12(1):2209201. PubMed ID: 37132361
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.
Wan EYF; Mok AHY; Yan VKC; Chan CIY; Wang B; Lai FTT; Chui CSL; Li X; Wong CKH; Lau CS; Wong ICK; Chan EWY
J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36250571
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study.
Yan VKC; Cheng FWT; Chui CSL; Lai FTT; Wong CKH; Li X; Wan EYF; Wong JSC; Chan EWY; Wong ICK; Kwan MYW; Ip P
Emerg Microbes Infect; 2023 Dec; 12(1):2185455. PubMed ID: 36852582
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study.
Yan VKC; Wan EYF; Ye X; Mok AHY; Lai FTT; Chui CSL; Li X; Wong CKH; Li PH; Ma T; Qin S; Wong VKC; Tsang TC; Tsui SH; Chui WCM; Cowling BJ; Leung GM; Lau CS; Wong ICK; Chan EWY
Emerg Microbes Infect; 2022 Dec; 11(1):2304-2314. PubMed ID: 35980089
[TBL] [Abstract][Full Text] [Related]
5. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.
Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW
Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
7. Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron.
Wei Y; Jia KM; Zhao S; Hung CT; Mok CKP; Poon PKM; Man Leung EY; Wang MH; Yam CHK; Chow TY; Guo Z; Yeoh EK; Chong KC
JAMA Netw Open; 2023 Feb; 6(2):e2254777. PubMed ID: 36735253
[TBL] [Abstract][Full Text] [Related]
8. Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data.
Kumwichar P; Poonsiri C; Botwright S; Sirichumroonwit N; Loharjun B; Thawillarp S; Cheewaruangroj N; Chokchaisiripakdee A; Teerawattananon Y; Chongsuvivatwong V
JMIR Public Health Surveill; 2024 Mar; 10():e48255. PubMed ID: 38441923
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKD.
Cheng FWT; Yan VKC; Wan EYF; Chui CSL; Lai FTT; Wong CKH; Li X; Chan CIY; Wang B; Tang SCW; Wong ICK; Chan EWY
Clin J Am Soc Nephrol; 2024 Apr; 19(4):418-428. PubMed ID: 38147590
[TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.
McMenamin ME; Nealon J; Lin Y; Wong JY; Cheung JK; Lau EHY; Wu P; Leung GM; Cowling BJ
Lancet Infect Dis; 2022 Oct; 22(10):1435-1443. PubMed ID: 35850128
[TBL] [Abstract][Full Text] [Related]
11. Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.
Cerqueira-Silva T; Katikireddi SV; de Araujo Oliveira V; Flores-Ortiz R; Júnior JB; Paixão ES; Robertson C; Penna GO; Werneck GL; Barreto ML; Pearce N; Sheikh A; Barral-Netto M; Boaventura VS
Nat Med; 2022 Apr; 28(4):838-843. PubMed ID: 35140406
[TBL] [Abstract][Full Text] [Related]
12. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
13. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study.
Wan EYF; Chui CSL; Wang Y; Ng VWS; Yan VKC; Lai FTT; Li X; Wong CKH; Chan EWY; Wong CSM; Leung KSM; Ni MY; Valkenburg SA; Peiris JSM; Wu JTK; Cowling BJ; Ashcroft DM; Hung IFN; Leung GM; Wong ICK
Lancet Reg Health West Pac; 2022 Apr; 21():100393. PubMed ID: 35128500
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers.
Çulpan HC; Aydın SN; Uygur A; Sayılı U; Şeker E; Balkan ILİ; Karaali R; Budak B; Keskindemirci Y; Saltoğlu N; Can G
Hum Vaccin Immunother; 2023 Dec; 19(3):2275445. PubMed ID: 37964650
[TBL] [Abstract][Full Text] [Related]
16. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization.
Wong CKH; Xiong X; Lau KTK; Chui CSL; Lai FTT; Li X; Chan EWY; Wan EYF; Au ICH; Cowling BJ; Lee CK; Wong ICK
BMC Med; 2022 Mar; 20(1):119. PubMed ID: 35296305
[TBL] [Abstract][Full Text] [Related]
17. Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
Suah JL; Husin M; Tok PSK; Tng BH; Thevananthan T; Low EV; Appannan MR; Muhamad Zin F; Mohd Zin S; Yahaya H; Peariasamy KM; Sivasampu S
Int J Infect Dis; 2022 Jun; 119():69-76. PubMed ID: 35331933
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study.
Paternina-Caicedo A; Quevedo DS; Ríos DS; Moyano D; Alvis-Guzmán N; Alviz-Zakzuk NR; Salcedo F; Moyano L; Ramírez-Suarez J; Smith AD; De la Hoz-Restrepo F
Vaccine; 2023 Oct; 41(42):6291-6299. PubMed ID: 37679278
[TBL] [Abstract][Full Text] [Related]
19. Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil.
Cerqueira-Silva T; de Araujo Oliveira V; Paixão ES; Júnior JB; Penna GO; Werneck GL; Pearce N; Barreto ML; Boaventura VS; Barral-Netto M
Nat Commun; 2022 Jul; 13(1):4154. PubMed ID: 35851597
[TBL] [Abstract][Full Text] [Related]
20. Risks of COVID-19-related hospitalisation and mortality among individuals with mental disorders following BNT162b2 and CoronaVac vaccinations: A case-control study.
Yiu HHE; Yan VKC; Wei Y; Ye X; Huang C; Castle DJ; Chui CSL; Lai FTT; Li X; Wong CKH; Wan EYF; Wong ICK; Chan EW
Psychiatry Res; 2023 Nov; 329():115515. PubMed ID: 37820573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
